InvestorsHub Logo
Followers 1
Posts 280
Boards Moderated 0
Alias Born 11/09/2012

Re: None

Friday, 05/11/2018 1:58:35 AM

Friday, May 11, 2018 1:58:35 AM

Post# of 843
Yield10 Bioscience's (YTEN) CEO Oli Peoples on Q1 2018 Results - Earnings Call Transcript
May.10.18
https://seekingalpha.com/article/4172681-yield10-biosciences-yten-ceo-oli-peoples-q1-2018-results-earnings-call-transcript?part=single

"We ended first quarter of 2018 with $11.6 million in cash, cash equivalents and short-term securities on the balance sheet."

"We expect our cash on hand together with revenue expected under current government grants to support our operations to a number of technology proof points into mid-2019."

"Monsanto is the world leader in developing biotech traits in soybean. So it’s great to have them working in C3003 with a unique capabilities and capacity. Our new business model for working with ag major, its also attracted the interest of other parties for both additional gene traits as well as other crops. We have some discussions ongoing and our goal is to work with additional ag companies to bring forward new yield traits."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent YTEN News